cosopt competitor intelligence
TRANSCRIPT
“Competitor Intelligence “Market overview
Assim Abdel Halim Professional Medical RepresentativeDBU – Merck Saudi Arabia
1. Who We Are . . !
*DORZOLAMIDE 2%+TIMOLOL 5%.*80 SR .*COMBINATION THERAPY.*CARBONIC ANHYDRAZE INHIBITOR + B-BLOKER.*MARKET LEADER.*THE MOST EFFECTIVE & TRUSTED ONE.*UNIQUE DEVICE.
*COSOPT PF : PRESERVATIVE FREE COMBINATION
COSOPT COSOPT PF* TRUSOPT TIMPOTOL
2. Our competitors :
ALLERGAN: ( Lumigan-Ganfort-Alphagan-Combigan ).
ALCON: ( Betoxolol- Travatan-Duotrov-Azopt-Azarga ).
PFIZER: ( Xalatan-Xalacom ).
3. Generic : Jamjoom xola-xolamol .
ALLERGAN BRANDS
ALCON BRANDS*Travantan(66
SR)*Travoprost 0.004%
*Monotharpy
*Duotrov (71.5 SR)*Travan + Timolol
5%*Combination.
*Azopt ( 44 SR ) *Brinzolamide 10%
*Monotherapy
*Azarga ( 64.80 SR)
*Azopt + Timolol 5%
*Combination therapy
*Betoptic (36.8 SR) *Betoxolol 5%*Monotherapy
PFIZER BRANDS
*Xalatan (76 SR )* Latanoprost
0.005%*Monotherapy
*Xalacom ( 89.5 SR )*Xalatan + 5%
Timolol*No Added value
than Xalatan.
Generic product( Jamjoom )
*Xola (34 SR)
*Dorzolami
de
*Xolamol (51 SR )
*Dorzolamid
e + Timolo
l
4. Who will be our main competitors ?
a) Combination dosage forms .b) Generic forms .
• Our key actions :* Clinical credibility – Rapport building – Adapting
our message – Optimum resources allocation.*Anti-generic campaign .
*BRAND vs GENERIC
Figure 1 : INNOVATION.VALUE FOR MONEY.
So, we can lead forever.
T H A N K S